Intelligent Nutraceutical Gel Systems

Publication ID: 24-11857593_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Nutraceutical Gel Systems,” Published Technical Disclosure No. 24-11857593_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857593_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,593.

Summary of the Inventive Concept

The present invention integrates nutraceutical gels with advanced technologies such as AI, IoT, blockchain, and novel biomaterials to create a new generation of personalized, adaptive, and secure health supplements.

Background and Problem Solved

The original patent disclosed nutraceutical gels with immune modulators and oligomeric proanthocyanidins. However, these gels lacked the ability to adapt to individual users' needs, were prone to counterfeiting, and had limited bioavailability. The new inventive concept addresses these limitations by incorporating AI-driven optimization, IoT-enabled health monitoring, blockchain-based tracking, and novel biomaterials to enhance bioavailability.

Detailed Description of the Inventive Concept

The inventive concept comprises a nutraceutical gel with an integrated AI module that optimizes the gel's composition based on a user's specific nutritional needs. The gel is also equipped with an IoT sensor that monitors the user's health metrics and adjusts the gel's composition accordingly. Additionally, the gel is tracked and verified using a blockchain-based platform, ensuring authenticity and quality control. Furthermore, the gel incorporates a novel biomaterial derived from a nanofraction immune modulator, enhancing bioavailability and absorption rate. The inventive concept also includes a smart packaging system with a microchip and sensor to monitor expiration date, storage conditions, and nutritional content.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and novel biomaterials into nutraceutical gels, which is not disclosed in the original patent. The inventive step lies in the synergistic combination of these technologies to create a personalized, adaptive, and secure health supplement system.

Alternative Embodiments and Variations

Alternative embodiments may include using different AI algorithms, IoT sensors, or blockchain platforms. Variations may include incorporating other advanced technologies, such as augmented reality or 5G connectivity, to further enhance the system's functionality and user experience.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the health and wellness industry, particularly in the areas of personalized nutrition, preventive medicine, and health monitoring. Target industries may include nutraceutical companies, healthcare providers, and wellness centers.

CPC Classifications

SectionClassGroup
A A61 A61K36/889
A A23 A23G4/12
A A23 A23L29/231
A A23 A23L29/238
A A23 A23L29/27
A A23 A23L29/271
A A23 A23L29/284
A A23 A23L33/10
A A23 A23L33/105
A A61 A61K36/185
A A61 A61K36/35
A A61 A61K36/87
A A61 A61K47/36
A A23 A23V2002/00
A A23 A23V2200/324
A A23 A23V2250/21
A A23 A23V2250/21166
A A23 A23V2250/506
A A23 A23V2250/5086
A A23 A23V2250/708
A A61 A61K2300/00

Field of Art

Nutraceutical formulation and food technology, specifically focused on gel-based supplement systems with immune modulators and functional ingredients. Requires expertise in food science, biochemistry, materials engineering, and nutritional supplement development

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in food science or biochemical engineering, experienced in supplement formulation, familiar with emerging technologies in personalized nutrition, and capable of integrating multiple technical domains

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies and advanced monitoring systems into nutraceutical gel formulations represents a predictable evolution of existing supplement technologies. The source patent's foundational work on gel-based immune modulators provides a clear technical framework for subsequent technological enhancements. The disclosed variations represent logical extensions of known supplement development strategies, utilizing standard engineering approaches to add functionality and personalization.

Obvious Combinations & Variations

Source Patent Element
Gel-based nutraceutical composition with transfer factor and oligomeric proanthocyanidin
PTD Variation
Adding AI-driven composition optimization module to dynamically adjust gel ingredients
Obviousness Reasoning
Predictable application of machine learning to personalized nutrition, representing a known technique for enhancing supplement effectiveness through adaptive formulation
Source Patent Element
Nutraceutical gel with immune modulator components
PTD Variation
Incorporating IoT sensor for real-time health metric monitoring and gel composition adjustment
Obviousness Reasoning
Routine integration of sensor technologies into health monitoring systems, following established design patterns in personalized healthcare technologies
Source Patent Element
Gel matrix containing fruit-derived proanthocyanidin extracts
PTD Variation
Blockchain-based tracking platform for verifying supplement origin and quality
Obviousness Reasoning
Standard supply chain authentication method applied to nutraceutical product verification, representing an obvious technological enhancement
Source Patent Element
Nanofraction immune modulator distribution in gel matrix
PTD Variation
Smart packaging with microchip for monitoring expiration, storage conditions, and nutritional content
Obviousness Reasoning
Logical extension of existing quality control technologies, applying known sensor and tracking methods to supplement preservation
35 U.S.C. § 103 Summary: Based on US Patent 11857593's disclosure of nutraceutical gel compositions, the present publication demonstrates that a person of ordinary skill in the art would find the integration of AI, IoT, blockchain, and advanced monitoring technologies into supplement systems an obvious technological progression. The variations represent predictable combinations of known techniques in personalized nutrition, supplement formulation, and digital health monitoring, thereby rendering subsequent claims of novelty obvious and non-patentable.

Original Patent Information

Patent NumberUS 11,857,593
TitleNutraceutical gels
Assignee(s)4Life Patents, LLC